Stock Taper
SCREENER COMPARE ANY 2 STOCKS
ANRO
ALTO NEUROSCIENCE, INC.
NYSE
$34.28
▲ UP 0.09% (0.03)

KEY STATISTICS

Market Cap$1.20 B
52w High$35.41
52w Low$3.41
Dividend Yield—
Frequency—
P/E-14.17
Volume238.71K
Shares Out.35.09M

COMPANY

LEADERSHIP

Amit Etkin
CHIEF EXECUTIVE
Amit Etkin

COMPENSATION 2026

Salary$650,671
Stock Awards$0
Incentive Plan Pay$358,072
All Other Comp.$25,558
Total$2,188,487

ABOUT

SECTOR
Healthcare
WENT PUBLIC
February 2, 2024
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
68

PRICE TARGET

Target High$55.00
Target Low$24.00
Target Median$36.00
Target Consensus$37.40

UPCOMING EARNINGS

DateNov 11, 2026
DayWednesday
Rev. Est.—
NOV
11
WED

PRICE

$34.28 ▲ UP 0.09% (+$0.03)
$34.00$34.40$34.80$35.209:30 AM10:35 AM11:40 AM12:44 PM1:49 PM2:54 PM3:59 PM34.28

About Alto Neuroscience, Inc.

https://www.altoneuroscience.com ↗

Alto Neuroscience, Inc., a Los Altos-based clinical-stage biopharma, develops innovative drugs for MDD, PTSD, and schizophrenia, utilizing AI-driven biomarkers and novel compounds like ALTO-100, ALTO-300, ALTO-101, ALTO-202, and ALTO-203.

INDUSTRY

Biotechnology

A PRODUCT ALTO NEUROSCIENCE, INC. IS KNOWN FOR

ALTO-300
ALTO-300

An oral small molecule in Phase 2b trials for MDD, developed as an adjunctive treatment for patients identified by EEG biomarkers, with positive interim results and full topline data expected in mid-2026.

COMPETITORS

COMPETITOR
AXSM COMPARE
CMPS COMPARE
RLMD COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
75
LISTED HERE
18
RANKED BY POSITION SIZE
VTI
0.00% · 1.0M
IWM
0.03% · 662.0K
XPH
1.42% · 238.1K
PSIL
5.06% · 85.1K
SBIO
0.60% · 41.3K
XRSG.L
0.03% · 24.0K
AVSC
0.02% · 21.4K
DFMC
0.01% · 20.2K
GSSC
0.06% · 18.8K
BBC
0.97% · 14.5K
RSSL
0.03% · 12.5K
PILL
0.95% · 6.8K
FESM
0.00% · 3.7K
RFLR
0.12% · 3.2K
URTY
0.01% · 1.1K
TNXT
0.08% · 427
RESM
0.05% · 91
SC0K.DE
0.03% · 0

INSTITUTIONAL OWNERSHIP

SHARES OWNED
57.13%
HOLDERS
127
TOP 12 OF 127 · RANKED BY POSITION SIZE
Alpha Wave Global, LP
3.7M sh · $66M
Commodore Capital LP
2.7M sh · $61.22M
Vestal Point Capital, LP
2.5M sh · $44.23M
Perceptive Advisors LLC
2.0M sh · $45.18M
Armistice Capital, LLC
1.6M sh · $6.58M
Point72 Asset Management, L.P.
1.6M sh · $28.6M
Vanguard Group Inc
1.4M sh · $24.31M
Franklin Resources Inc
1.2M sh · $4.67M
Vivo Capital, LLC
1.0M sh · $18.43M
Marshall Wace, Llp
825.2K sh · $3.32M
Millennium Management LLC
822.0K sh · $18.48M
72 Investment Holdings, LLC
667.8K sh · $11.89M

RATINGS SNAPSHOT

Overall rating: C+

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity4
Price To Earnings1
Price To Book2
Overall Score2

INSIDER TRADES

★
DIRECTOR
Miller Andrew Craig
Purchase · 26.0K shares
2026-05-27
★
DIRECTOR:
Miller Andrew Craig
— · —
2026-05-27
★
DIRECTOR, OFFICER: PRESIDENT AND CEO
Etkin Amit
Sale · 400.0K shares
2026-05-14
★
DIRECTOR
Sanchez Ramiro
Purchase · 11.0K shares
2026-05-12

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 5
NEUTRAL 1
OUTPERFORM 1
7 GRADES IN THE LAST 12 MONTHS
HC Wainwright & Co. BUY BTIG BUY Wedbush NEUTRAL Baird OUTPERFORM Chardan Capital BUY Jones Trading BUY Jefferies BUY

SECTORS PEERS

PEERPRICE
DRTS$14.92COMPARE
CTNM$17.19COMPARE
SLN$13.27COMPARE
LRMR$4.18COMPARE
DBVT$14.55COMPARE
CLLS$3.40COMPARE
ACIU$2.90COMPARE
AMRN$14.09COMPARE